Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Oncolytics Biotech Inc
ONCY
Primary Symbol:
T.ONC
Healthcare
Biotechnology
Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune...
responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:ONC)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(83)
•••
Quentin30
X
View Profile
View Bullboard History
Comment by
Quentin30
on Jun 11, 2024 12:38pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Type C Meeting Timings
Stocks are doing fine thanks Azzak... quiet ? there's not really much to post about... we're waiting on news from ONCY on how they will pay for x2 Phase IIIs, and whether either will go
...more
(486)
•••
Lesalpes29
X
View Profile
View Bullboard History
Comment by
Lesalpes29
on Jun 11, 2024 11:26am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:I agree 109%….
No interest for sure! We have to stop with the manipulation none sense or short action. No interest and Matt is not interested to sell cheap and BP wants to buy us cheap. Maybe! Probably less than
...more
(5649)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Jun 11, 2024 11:17am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Type C Meeting Timings
Re: Considerations for Discussion of a New Surrogate Endpoint(s) at a Type C PDUFA Meeting Request" - Prescription Drug User Fee Act (PDUFA) was enacted in 1992 - Leading up to PDUFA
...more
(5649)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Jun 11, 2024 11:04am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Type C Meeting Timings
From the FDA directive on " Considerations for Discussion of a New Surrogate Endpoint(s) at a Type C PDUFA Meeting Request" "FDA and industry believe that early consultation
...more
(1402)
•••
Azzak34
X
View Profile
View Bullboard History
Comment by
Azzak34
on Jun 11, 2024 10:59am
RE:RE:RE:RE:RE:RE:RE:RE:RE:Type C Meeting Timings
I can answer this one!! He quoted exactly what a Type C meeting is for and what that means. Have a pop at gaining knowledge and posting facts, rather than the speculation you accuse others of.&
...more
(83)
•••
Quentin30
X
View Profile
View Bullboard History
Comment by
Quentin30
on Jun 11, 2024 10:57am
RE:RE:RE:RE:RE:RE:RE:RE:Type C Meeting Timings
well done, you can copy and paste like a trooper can't you Noteable.!! A sponsor will always request a Face to Face meeting... FDA decides whether this is necessary or not... it's quite
...more
(5649)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Jun 11, 2024 10:56am
RE:RE:RE:RE:RE:RE:RE:RE:RE:Type C Meeting Timings
Type C meetings that set up the use of a biomarker as a new surrogate endpoint also set the stage for an Accelerted Approval request.
(5649)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Jun 11, 2024 10:53am
RE:RE:RE:RE:RE:RE:RE:RE:Type C Meeting Timings
Type C meetings are reserved for issues that do not fit in the Type A or B categories and can be used to consult on the use of a biomarker as a new surrogate endpoint that has never before been used.
(5649)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Jun 11, 2024 10:39am
RE:RE:RE:RE:RE:RE:RE:Type C Meeting Timings
Type C FDA meetings are a "catch-all" category and include any meeting concerning the development and review of a product that does not fall within the scope of Types A or B. The FDA notes
...more
(64)
•••
venture009
X
View Profile
View Bullboard History
Comment by
venture009
on Jun 11, 2024 10:30am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:I agree 109%….
Quentin a sobering view but certainly one that has played out with this company, what seems forever. The elusive buyout/partner never arrives and the current action on stock suggests we are no closer
...more
(83)
•••
Quentin30
X
View Profile
View Bullboard History
Comment by
Quentin30
on Jun 11, 2024 10:14am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:I agree 109%….
Stock Price looking strong again... Even more chances to buy under a dollar..?? This certainly doesn't trade as though a BIG deal is in the works. Just to clear up any confusion, the Type C
...more
(295)
•••
inthno
X
View Profile
View Bullboard History
Comment by
inthno
on Jun 10, 2024 11:39pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:I agree 109%….
So Just curious what we consider near term horizon when it has basically been stated that the panc will not start until sometime in 2025 and the mbc fda meeting is only for guidance to set up a phase
...more
(5649)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Jun 10, 2024 8:55pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:I agree 109%….
Not with 2 registration studies on the near term horizon.
(211)
•••
Buckhenry
X
View Profile
View Bullboard History
Comment by
Buckhenry
on Jun 10, 2024 8:31pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:I agree 109%….
That delisting letter getting typed up now....
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
A Low Cost Natural Gas Producer for Your Portfolio
A Junior Copper-Gold Stock Trading at a Bargain of Monumental Proportions